| 26.71 1.36 (5.36%) | 04-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 38.62 | 1-year : | 45.18 |
| Resists | First : | 33.06 | Second : | 38.68 |
| Pivot price | 27.49  |
|||
| Supports | First : | 23.96 | Second : | 19.94 |
| MAs | MA(5) : | 26.41 |
MA(20) : | 28.37 |
| MA(100) : | 33.97 |
MA(250) : | 24.99 |
|
| MACD | MACD : | -2.4 |
Signal : | -2.6 |
| %K %D | K(14,3) : | 23.6 |
D(3) : | 24.5 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 72.98 | Low : | 11.19 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HIMS ] has closed above bottom band by 37.2%. Bollinger Bands are 62.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 29.04 - 29.2 | 29.2 - 29.35 |
| Low: | 26.02 - 26.22 | 26.22 - 26.4 |
| Close: | 26.42 - 26.71 | 26.71 - 26.97 |
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Wed, 23 Apr 2025
Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy (NYSE:HIMS) - Seeking Alpha
Wed, 23 Apr 2025
FDA Warns of Side Effects of Popular Hair-Loss Drug Sold by Telehealth Companies - WSJ
Wed, 23 Apr 2025
Hims & Hers Stock (HIMS) Dips After FDA Flags Safety Concerns - TipRanks
Tue, 22 Apr 2025
FDA issues warning on hair-loss treatment sold on Hims & Hers - Sherwood News
Tue, 22 Apr 2025
FDA issues warning over compounded finasteride for hair loss - Seeking Alpha
Tue, 22 Apr 2025
Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 0 (M) |
| Shares Float | 214 (M) |
| Held by Insiders | 1.9263e+008 (%) |
| Held by Institutions | 11.2 (%) |
| Shares Short | 46,120 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 826.79 |
| Profit Margin | 8.5 % |
| Operating Margin | 4.6 % |
| Return on Assets (ttm) | 7.1 % |
| Return on Equity (ttm) | 30.7 % |
| Qtrly Rev. Growth | 95 % |
| Gross Profit (p.s.) | 7.09091e+008 |
| Sales Per Share | 8.9697e+008 |
| EBITDA (p.s.) | 5.03515e+007 |
| Qtrly Earnings Growth | 1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 251 (M) |
| PE Ratio | 50.38 |
| PEG Ratio | 0 |
| Price to Book value | 0.03 |
| Price to Sales | 0 |
| Price to Cash Flow | 20.39 |
| Dividend | 0 |
| Forward Dividend | 5.473e+007 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|